informed consent,
Item
signed informed consent,
boolean
C0021430 (UMLS CUI [1])
Age, gender, postmenopausal
Item
post-menopausal women ≤75 years,
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
invasive breast carcinoma, metastases
Item
histologically confirmed invasive breast carcinoma (no distant metastases),
boolean
C0678222 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2])
hormone receptor status
Item
positive hormone receptor status,
boolean
C0019929 (UMLS CUI [1])
tamoxifen
Item
continuous 2-year adjuvant tamoxifen therapy 20 mg/30 mg with 4 weeks after primary surgery
boolean
C0039286 (UMLS CUI [1])
menopause status
Item
menopause status maintained by medication,
boolean
C0455962 (UMLS CUI [1])
pre-operative therapy
Item
pre-operative chemotherapy or hormone therapy or radiation therapy,
boolean
C0600558 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
relapse and other malignant neoplasms
Item
relapse or second carcinoma or previous cancerous disease,
boolean
C0277556 (UMLS CUI [1])
C0006826 (UMLS CUI [2])
breast carcinoma in situ
Item
breast carcinoma in situ,
boolean
C0678222 (UMLS CUI [1,1])
C0007099 (UMLS CUI [1,2])
simultaneous carcinoma of the opposite side
Item
simultaneous carcinoma of the opposite side or secondary breast,
boolean
C0678222 (UMLS CUI [1,1])
C0441988 (UMLS CUI [1,2])
lymph nodes
Item
10 or more tumour-infiltrated lymph nodes.
boolean
C0024204 (UMLS CUI [1])
comorbidities
Item
serious accompanying diseases
boolean
C0009488 (UMLS CUI [1])